BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells

Gene Therapy

Volumn 20, Issue 4, 2013, Pages 370-377

  Mizrahi, O ^a   Sheyn, D ^b   Tawackoli, W ^b   Kallai, I ^b   Oh, A ^a   Su, S ^b   Da, X ^b   Zarrini, P ^b   Cook Wiens, G ^b   Gazit, D ^a,b   Gazit, Z ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

bone formation; bone morphogenetic proteins; mesenchymal stem cells; nucleofection

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; GREEN FLUORESCENT PROTEIN; PLASMID VECTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE REMODELING; CELL VIABILITY; FRACTURE; GENE OVEREXPRESSION; GENE TRANSFER; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; NONVIRAL GENE THERAPY; NUCLEOFECTION; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SWINE; TISSUE REGENERATION;

ADIPOSE TISSUE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; CELL DIFFERENTIATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; SWINE; TRANSCRIPTION, GENETIC; TRANSFECTION;

SUS;

EID: 84875954737     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2012.45     Document Type: Article

References (52)

1. Gautschi OP, Frey SP, Zellweger R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 2007; 77: 626-631.
2. Lichte P, Pape HC, Pufe T, Kobbe P, Fischer H. Scaffolds for bone healing: concepts, materials and evidence. Injury 2011; 42: 569-573.
3. Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de Ruiter A et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA 2010; 107: 13614-13619.
4. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
5. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-192.
6. Krampera M, Pizzolo G, Aprili G, Franchini M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 2006; 39: 678-683.
7. Turgeman G, Pittman DD, Mü ller R, Kurkalli BG, Zhou S, Pelled G et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 2001; 3: 240-251.
8. Sheyn D, Kallai I, Tawackoli W, Cohn Yakubovich D, Oh A, Su S et al. Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol Pharm 2011; 8: 1592-1601.
9. Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Therapy 2008; 15: 257-266.
10. Aslan H, Zilberman Y, Kandel L, Liebergall M, Oskouian RJ, Gazit D et al. Osteo-genic differentiation of noncultured immunoisolated bone marrow-derived CD105 + cells. Stem Cells 2006; 24: 1728-1737.
11. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D. Review: gene-and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007; 13: 1135-1150.
12. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 2008; 283: 20948-20958.
13. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Therapy 2004; 11: 1312-1320.
14. Kimelman-Bleich N, Pelled G, Zilberman Y, Kallai I, Mizrahi O, Tawackoli W et al. Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Mol Ther 2011; 19: 53-59.
15. Sheyn D, Rüthemann M, Mizrahi O, Kallai I, Zilberman Y, Tawackoli W et al. Genetically modified mesenchymal stem cells induce mechanically stable posterior spine fusion. Tissue Eng Part A 2010; 16: 3679-3686.
16. Paul S, Lee JC, Yeh LC. A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells. Growth Factors 2009; 27: 121-131.
17. Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 2007; 25: 665-677.
18. Zachos TA, Shields KM, Bertone AL Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins -2 or -6. J Orthop Res 2006; 24: 1279-1291.
19. Carpenter RS, Goodrich LR, Frisbie DD, Kisiday JD, Carbone B, McIlwraith CW et al. Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone. J Orthop Res 2010; 28: 1330-1337.
20. Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Therapy 2003; 10: 1735-1743.
21. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-1552.
22. Kofron MD, Laurencin CT. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 2006; 58: 555-576.
23. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M et al. Nucleofec-tion-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 2006; 12: 877-889.
24. Hasharoni A, Zilberman Y, Turgeman G, Helm GA, Liebergall M, Gazit D. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J Neurosurg Spine 2005; 3: 47-52.
25. Moutsatsos IK, Turgeman G, Zhou S, Kurkalli BG, Pelled G, Tzur L et al. Exo-genously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 2001; 3: 449-461.
26. Sheyn D, Pelled G, Zilberman Y, Talasazan F, Frank JM, Gazit D et al. Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion. Stem Cells 2008; 26: 1056-1064.
27. Santos JL, Pandita D, Rodrigues J, Pêgo AP, Granja PL, Tomas H. Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. Curr Gene Ther 2011; 11: 46-57.
28. Zaragosi LE, Billon N, Ailhaud G, Dani C. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells 2007; 25: 790-797.
29. Sheyn D, Mizrahi O, Benjamin S, Gazit Z, Pelled G, Gazit D. Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev 2010; 62: 683-698.
30. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D et al. Review: gene-and stem cell-based therapeutics for bone regeneration and repair. Tissue engineering 2007; 13: 1135-1150.
31. Kimelman BN, Kallai I, Lieberman JR, Schwarz EM, Pelled G, Gazit D. Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev 2012; e-pub ahead of print 10 March 2012.
32. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM et al. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 1996; 137: 3401-3407.
33. Vukicevic S, Grgurevic L. BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev 2009; 20: 441-448.
34. Levi B, Longaker MT. Concise review: adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells 2011; 29: 576-582.
35. Cavallo C, Cuomo C, Fantini S, Ricci F, Tazzari PL, Lucarelli E et al. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J Cell Biochem 2011; 112: 1418-1430.
36. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33: 1402-1416.
37. Hayashi O, Katsube Y, Hirose M, Ohgushi H, Ito H. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 2008; 82: 238-247.
38. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthr Cartil 2005; 13: 845-853.
39. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14: 311-324.
40. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-1301.
41. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174: 101-109.
42. Niemeyer P, Fechner K, Milz S, Richter W, Suedkamp NP, Mehlhorn AT et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 2010; 31: 3572-3579.
43. Jane Jr JA, Dunford BA, Kron A, Pittman DD, Sasaki T, Li JZ et al. Ectopic osteo-genesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 2002; 6: 464-470.
44. Simic P, Culej JB, Orlic I, Grgurevic L, Draca N, Spaventi R et al. Systemically administered bone morphogenetic protein-6 restores bone in aged ovariec-tomized rats by increasing bone formation and suppressing bone resorption. J Biol Chem 2006; 281: 25509-25521.
45. Muchow RD, Hsu WK, Anderson PA. Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion. Spine J 2010; 10: e1-e6.
46. Perri B, Cooper M, Lauryssen C, Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 2007; 7: 235-239.
47. Deutsch H. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth. Spine J 2010; 10: e1-e4.
48. Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod 2006; 74: 46-57.
49. Calve S, Dennis RG, Kosnik 2nd PE, Baar K, Grosh K, Arruda EM. Engineering of functional tendon. Tissue Eng 2004; 10: 755-761.
50. Kallai I, Mizrahi O, Tawackoli W, Gazit Z, Pelled G, Gazit D. Microcomputed tomography-based structural analysis of various bone tissue regeneration models. Nat Protoc 2011; 6: 105-110.
51. Muller R, Ruegsegger P. Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud Health Technol Inform 1997; 40: 61-79.
52. Hildebrand T, Laib A, Müller R, Dequeker J, Rü egsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999; 14: 1167-1174.